A citation-based method for searching scientific literature




Roy S Herbst, Paul Baas, Dong-Wan Kim, Enriqueta Felip, José L Pérez-Gracia, Ji-Youn Han, Julian Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung-Ju Ahn, Margarita Majem, Mary J Fidler, Gilberto de Castro, Marcelo Garrido, Gregory M Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled-Filhart, Edward B Garon. Lancet 2016
Times Cited: 3515




List of shared articles



Times cited

A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival.
Tolga Turan, Sarah Kongpachith, Kyle Halliwill, Jessica Roelands, Wouter Hendrickx, Francesco M Marincola, Thomas J Hudson, Howard J Jacob, Davide Bedognetti, Josue Samayoa,[...]. Br J Cancer 2021
2

The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma.
Yong Cheng, Yanxiang Zhang, Yuwei Yuan, Jiao Wang, Ke Liu, Bin Yu, Li Xie, Chao Ou-Yang, Lin Wu, Xiaoqun Ye. Front Genet 2021
0

KRAS G12C inhibition and innate immune targeting.
Tetsuo Tani, Shunsuke Kitajima, Ella B Conway, Erik H Knelson, David A Barbie. Expert Opin Ther Targets 2021
1

Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.
Michael J Grant, Roy S Herbst, Sarah B Goldberg. Nat Rev Clin Oncol 2021
4

Veliparib and nivolumab in combination with platinum doublet chemotherapy in patients with metastatic or advanced non-small cell lung cancer: A phase 1 dose escalation study.
Jeffrey M Clarke, Jyoti D Patel, Francisco Robert, Ebenezer A Kio, Eddie Thara, D Ross Camidge, Martin Dunbar, Silpa Nuthalapati, Minh H Dinh, Bruce A Bach. Lung Cancer 2021
0

Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma.
Na Qin, Yuancheng Li, Cheng Wang, Meng Zhu, Juncheng Dai, Tongtong Hong, Demetrius Albanes, Stephen Lam, Adonina Tardon, Chu Chen,[...]. Front Med 2021
6